Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Theratechnologies (TH.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 362,451
  • Shares Outstanding, K 76,953
  • Annual Sales, $ 44,099 K
  • Annual Income, $ -4,529 K
  • 60-Month Beta 0.39
  • Price/Sales 4.58
  • Price/Cash Flow N/A
  • Price/Book 9.11
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.09
  • Most Recent Earnings -0.02 on 08/31/19
  • Next Earnings Date 10/08/19
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.26 +10.56%
on 10/18/19
5.46 -13.74%
on 10/24/19
-0.14 (-2.89%)
since 10/15/19
3-Month
4.26 +10.56%
on 10/18/19
6.02 -21.76%
on 09/20/19
-0.70 (-12.94%)
since 08/15/19
52-Week
4.26 +10.56%
on 10/18/19
9.74 -51.64%
on 01/07/19
-2.51 (-34.76%)
since 11/15/18

Most Recent Stories

More News
Theratechnologies' CFO to Attend Stifel Healthcare Conference in New York City

Theratechnologies Inc. (Theratechnologies) (TSX: TH), a commercial-stage biopharmaceutical company, is pleased to announce that Philippe Dubuc, Senior Vice President and Chief Financial Officer, will attend...

THERF : 3.8000 (+4.68%)
TH.TO : 4.71 (-2.28%)
THTX : 3.59 (-1.10%)
Trogarzo(R) Remains Effective Close to a Decade After Treatment Initiation

MONTREAL, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that data presented...

THERF : 3.8000 (+4.68%)
TH.TO : 4.71 (-2.28%)
THTX : 3.59 (-1.10%)
Theratechnologies Provides Details About R&D Day Webcast

Theratechnologies Inc. ("Theratechnologies" or the "Company") (NASDAQ: THTX) (TSX: TH), a commercial-stage pharmaceutical company addressing unmet medical needs for people with orphan medical conditions,...

THERF : 3.8000 (+4.68%)
THTX : 3.59 (-1.10%)
TH.TO : 4.71 (-2.28%)
REMINDER - Tesamorelin Study Results on NAFLD Published in Lancet HIV

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX) is pleased to announce that results from a recent trial conducted at the Massachusetts General Hospital and the National Institute of...

THERF : 3.8000 (+4.68%)
TH.TO : 4.71 (-2.28%)
THTX : 3.59 (-1.10%)
Tesamorelin Study Results on NAFLD Published in Lancet HIV

Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX) is pleased to announce that results from a recent trial conducted at the Massachusetts General Hospital and the National Institute of...

THERF : 3.8000 (+4.68%)
TH.TO : 4.71 (-2.28%)
THTX : 3.59 (-1.10%)
Canadian Commercial-Stage Biopharmaceutical Company Theratechnologies Announces NASDAQ Listing

Theratechnologies Inc. ("Theratechnologies" or the "Company") (TSX: TH), a commercial-stage biopharmaceutical company addressing unmet medical needs for people with orphan medical conditions, including...

THERF : 3.8000 (+4.68%)
TH.TO : 4.71 (-2.28%)
THTX : 3.59 (-1.10%)
Theratechnologies Announces Financial Results for the Third Quarter of 2019

Theratechnologies Inc. (Theratechnologies) (TSX: TH) today announced its financial results for the third quarter ended August 31, 2019.

THERF : 3.8000 (+4.68%)
TH.TO : 4.71 (-2.28%)
1.7 Million Dollars Grant Towards Development of Theratechnologies' Targeted Oncology

Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that the Canadian Cancer Society and the Government of Quebec, through the Consortium Quebecois sur la decouverte du medicament...

THERF : 3.8000 (+4.68%)
TH.TO : 4.71 (-2.28%)
New 48-Week Data Presented at IDWeek Show Trogarzo(R) Remains Safe and Effective

Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that new 48-week data from the TMB-311 extension study confirm that Trogarzoprovides durable viral suppression and a safety profile...

THERF : 3.8000 (+4.68%)
TH.TO : 4.71 (-2.28%)
Theratechnologies to Announce Financial Results for Third Quarter 2019

Theratechnologies Inc. (TSX: TH) (Theratechnologies) announced today that it will issue its financial results for the third quarter ended August 31, 2019, on Tuesday, October 8, 2019.

THERF : 3.8000 (+4.68%)
TH.TO : 4.71 (-2.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More Share

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar